Pulling Back The Curtain On Biopharma Partnering In Cell And Gene Therapies
Janssen, Biogen And Astellas Execs Discuss Portfolio Priorities
Executive Summary
Therapeutic areas and unmet needs drive big company decision-making about when and what technologies to bring in from external sources, executives explained during a panel at the 2020 Cell and Gene Therapy Meeting on the Mesa.